SynthesisPloS one2014

Increased risk of cerebrovascular events in patients with cancer treated with bevacizumab: a meta-analysis.

Pei-Yuan Zuo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.